NEW YORK ( TheStreet) -- ArthroCare Corporation (Nasdaq: ARTC) hit a new 52-week low Monday as it is currently trading at $26.20, below its previous 52-week low of $26.27 with 125,343 shares traded as of 3:09 p.m. ET. Average volume has been 150,300 shares over the past 30 days.

ArthroCare has a market cap of $754.4 million and is part of the health care sector and health services industry. Shares are down 14% year to date as of the close of trading on Friday.

ArthroCare Corporation, a medical device company, develops, manufactures, and markets surgical products primarily based on its minimally invasive patented Coblation technology. The company has a P/E ratio of 28, above the average health services industry P/E ratio of 27.7 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates ArthroCare as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, unimpressive growth in net income and disappointing return on equity. You can view the full ArthroCare Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

ArthroCare Corp Stock Downgraded (ARTC)

ArthroCare Corp Stock Downgraded (ARTC)

Insider Trading Alert - CRZO, ARTC, MDCO, ED And LNG Traded By Insiders

Insider Trading Alert - CRZO, ARTC, MDCO, ED And LNG Traded By Insiders

3 Health Care Stocks Rising on Big Volume

3 Health Care Stocks Rising on Big Volume

Jim Cramer's 6 Stocks in 60 Seconds: CVX SNN NSC RDS.A P AOL (Update 1)

Jim Cramer's 6 Stocks in 60 Seconds: CVX SNN NSC RDS.A P AOL (Update 1)

S&N Pays $1.5B For Sports Medicine Specialist ArthroCare

S&N Pays $1.5B For Sports Medicine Specialist ArthroCare